RxDoctor Payments Data

Diane Settles, MD

Gastroenterology · Ashland, KYNPI 1356462154

Payments from drug & device makers

$4,934in general payments, 2019–2025

Across 299 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$858
  • Johnson & Johnson$386
  • Ironwood Pharmaceuticals, Inc$302
  • Gilead$269
  • Takeda Pharmaceuticals U.S.A., Inc.$247
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,88899%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,934 in reported general payments places this provider in the 55th percentile of 207 gastroenterology providers in Kentucky.

See all gastroenterology providers in Kentucky

Medicare billing

Part B allowed, 2024
$149,149
Medicare patients
630
Services billed
1,406

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab37$965,754
EntyvioVedolizumab17$149,460
Humira(Cf) PenAdalimumab17$146,604
LinzessLinaclotide112$112,065
XifaxanRifaximin25$79,361
TrulancePlecanatide14$19,850
Dexlansoprazole DrDexlansoprazole43$17,173
MotegrityPrucalopride Succinate20$13,318
Omeprazole519$7,395
Budesonide DrBudesonide31$6,972
Mesalamine11$6,810
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates97$6,170
Ursodiol34$5,449
Esomeprazole Magnesium124$5,157
SutabSod Sulf/Pot Chloride/Mag Sulf26$4,215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$386$965,75437 claims
Takeda Pharmaceuticals U.S.A., Inc.Entyvio, Motegrity$247$162,77837 claims
AbbVieLinzess$1,671$112,065112 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$858$99,21139 claims
Braintree Laboratories, Inc.Sutab$20$4,21526 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 207 gastroenterology providers in Kentucky.

Other gastroenterology in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →